744471
Last Update Posted: 2021-02-26
Recruiting has ended
All Genders accepted | 18 Years-99 Years |
627 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Tanezumab in Osteoarthritis Of The Hip
The purpose of this study is to test the efficacy and safety of 3 doses of tanezumab in osteoarthritis of the hip in patients
Eligibility
Relevant conditions:
Arthritis
Osteoarthritis
Osteoarthritis, Hip
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov